Tyra Biosciences, Inc.
NASDAQ:TYRA
16.39 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.353 | 0.296 | 0.14 | 0.047 | 0.008 |
| Gross Profit
| -0.353 | -0.296 | -0.14 | -0.047 | -0.008 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 62.518 | 43.008 | 20.636 | 7.203 | 1.79 |
| General & Administrative Expenses
| 17.427 | 15.919 | 5.652 | 2.094 | 1.332 |
| Selling & Marketing Expenses
| 17.41 | 0 | 0 | 0 | 0 |
| SG&A
| 17.427 | 15.919 | 5.652 | 2.094 | 1.332 |
| Other Expenses
| 0 | -0.05 | -0.019 | -0.023 | -0.008 |
| Operating Expenses
| 79.945 | 58.927 | 26.288 | 9.297 | 3.122 |
| Operating Income
| -79.945 | -58.927 | -26.288 | -9.297 | -3.122 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 10.811 | 3.602 | -0.006 | -0.039 | -0.943 |
| Income Before Tax
| -69.134 | -55.325 | -26.294 | -9.336 | -4.065 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -3.602 | -0.153 | -0.022 | -0.007 |
| Net Income
| -69.134 | -51.723 | -26.141 | -9.314 | -4.058 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.62 | -1.23 | -0.63 | -0.22 | -0.095 |
| EPS Diluted
| -1.62 | -1.23 | -0.63 | -0.22 | -0.095 |
| EBITDA
| -79.592 | -58.927 | -26.288 | -9.273 | -3.122 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |